Patents Assigned to KYNAN DUKE IP, LLC
  • Publication number: 20230159421
    Abstract: The present disclosure relates to substituted hydroxystilbene compounds and derivatives, specifically 2-substituted hydroxystilbene compounds and derivatives, the synthesis of such compounds and their use in therapy.
    Type: Application
    Filed: December 23, 2020
    Publication date: May 25, 2023
    Applicant: Kynan Duke IP, LLC
    Inventors: Colin Charles Duke, Rujee Kyokajee DUKE, Van Hoan TRAN
  • Patent number: 11634375
    Abstract: A compound according to structure USYDS1: wherein the compound is in purified form.
    Type: Grant
    Filed: May 26, 2022
    Date of Patent: April 25, 2023
    Assignee: KYNAN DUKE IP, LLC
    Inventors: Colin Charles Duke, Van Hoan Tran, Rujee Kyokajee Duke
  • Publication number: 20220380285
    Abstract: A compound, composition, or method for treating cancer is disclosed. The compound (that can be used in the composition and/or method) can include or pharmaceutically acceptable salts or solvates thereof. R1a-R1d, R2-R3 (and R4 where applicable), and A---B can be as defined herein.
    Type: Application
    Filed: May 26, 2022
    Publication date: December 1, 2022
    Applicant: Kynan Duke IP, LLC
    Inventors: Colin Charles Duke, Van Hoan TRAN, Rujee Kyokajee DUKE
  • Patent number: 11352310
    Abstract: A compound, composition, or method for treating cancer is disclosed. The compound (that can be used in the composition and/or method) can include or pharmaceutically acceptable salts or solvates thereof. R1a-R1d, R2-R3 (and R4 where applicable), and A---B can be as defined herein.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: June 7, 2022
    Assignee: KYNAN DUKE IP, LLC
    Inventors: Colin Charles Duke, Van Hoan Tran, Rujee Kyokajee Duke
  • Patent number: 11331299
    Abstract: The present disclosure is drawn to methods of treating diseases or disorders, and uses of preparing medicaments. The methods of administering and/or preparation of medicaments can include the use of a compound of Formula (I) disclosed herein, or a geometric isomer, stereoisomer, and/or pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: December 16, 2020
    Date of Patent: May 17, 2022
    Assignee: Kynan Duke IP, LLC
    Inventors: Colin Charles Duke, Rujee Kyokajee Duke, Van Hoan Tran